Sokolov and co-workers have developed an EGFR-targeted AuNPs for active targeting PAI, and demonstrated that 5 nm AuNPs could work as well as the 40 nm AuNPs with a comparable PA signal (Figure 4a), but 5 nm AuNPs showed outstanding tumor penetration and clearance [70]. Here, EGFR is linked to neoplasm.